All Articles

With a novel drug targeting an unaddressed cause of glaucoma, Qlaris Bio adds a seasoned expert to its board, signaling a pivotal push toward market entry.

New benchmarks show EDB Postgres AI outperforming rivals, challenging the architectural status quo and arguing that a unified data foundation is the future.

As hospitals acquire private practices at a record pace, a new platform offers independent physicians the same data-driven edge to survive and thrive.

A new class of disposable devices makes a common surgery four times faster and five times less bloody. So why is this Asia-led innovation invisible to US regulators?

Jewelry firm 25karats has launched a free online tool providing real-time melt values for gold, silver, and platinum to empower consumers.

Despite a sales slump, Monro's strategic cost cuts and operational overhaul are driving a surprising profit recovery. Is this the start of a lasting turnaround?

After a stellar Q1 and credit upgrade, all eyes are on Alliance Laundry's upcoming earnings. We dissect the trends and strategies that will define its success.

Uber Eats is adding regional grocers to its platform, a move that goes beyond convenience to challenge Instacart and DoorDash in the $250B online grocery war.

Processa Pharmaceuticals acquires Vidya Therapeutics and its key asset, VT-7208, backed by a $200M financing that radically overhauls the company's strategy.

A former nuclear site in Kentucky is the seed for a $100B AI hub, promising jobs and a new energy model. But can it overcome a toxic legacy and truly protect ratepayers?

Qnovia secures a license for a novel peptide, D8, that kills superbugs differently. Can this university-born innovation turn the tide on antibiotic resistance?

A new government partnership with AI firm Quantifind signals a tectonic shift in how the U.S. protects its vital communications from hidden foreign threats.

Rabobank North America's appointment of a 20-year tech veteran as COO signals a major shift, prioritizing digital resilience to fortify its critical food and energy financing.

A vision of tokenized stocks capturing a new generation of investors is powerful, but the reality is a complex tightrope walk over regulatory and technical hurdles.

PetIQ's acquisition of MYOS Corp and its muscle-preserving Fortetropin® signals a major shift in the booming pet wellness market toward science-backed longevity.

A new partnership integrates granular ad-spend data with massive viewership insights, promising advertisers unprecedented clarity and challenging legacy giants.

Hyro's new executive hires signal a market shift from AI pilots to full-scale deployment. Is healthcare ready for the operational overhaul of agentic AI?

A new report reveals how the 'secure' network protocol SNMPv3 gives attackers a roadmap, a flaw now weaponized by AI just as agencies warn of state-sponsored hacks.

The world’s largest derivatives exchange is launching futures based on sports performance, creating a new asset class and a new way to manage risk.